Cargando…

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target

Leucine-rich alpha-2-glycoprotein 1 (LRG1) is present abundantly in the microenvironment of many tumours where it contributes to vascular dysfunction, which impedes the delivery of therapeutics. In this work we demonstrate that LRG1 is predominantly a non-internalising protein. We report the develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javaid, Faiza, Pilotti, Camilla, Camilli, Carlotta, Kallenberg, David, Bahou, Calise, Blackburn, Jack, R. Baker, James, Greenwood, John, Moss, Stephen E., Chudasama, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341842/ https://www.ncbi.nlm.nih.gov/pubmed/34458833 http://dx.doi.org/10.1039/d1cb00104c

Ejemplares similares

LRG1: an emerging player in disease pathogenesis
por: Camilli, Carlotta, et al.
Publicado: (2022)

Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential
por: Gutiérrez-Fernández, Javier, et al.
Publicado: (2022)

Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway
por: Dritsoula, Athina, et al.
Publicado: (2022)

Publisher Correction: Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway
por: Dritsoula, Athina, et al.
Publicado: (2022)

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients
por: Popova, Anna, et al.
Publicado: (2022)

Comparison of leucine-rich alpha-2-glycoprotein-1 (LRG-1) plasma levels between patients with and without appendicitis, a case–controlled study
por: Lontra, Marcelo Bentancor, et al.
Publicado: (2021)

Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2023)

Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones
por: Bahou, Calise, et al.
Publicado: (2018)

LRG1 as a novel therapeutic target in eye disease
por: De Rossi, Giulia, et al.
Publicado: (2022)

Correction: LRG1 as a novel therapeutic target in eye disease
por: De Rossi, Giulia, et al.
Publicado: (2022)

A Plug-and-Play Platform for the Formation of Trifunctional Cysteine Bioconjugates that also Offers Control over Thiol Cleavability
por: Bahou, Calise, et al.
Publicado: (2021)

Correction: Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation
por: Bahou, Calise, et al.
Publicado: (2022)

Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway
por: Miao, Youhan, et al.
Publicado: (2022)

LRG1 promotes angiogenesis by modulating endothelial TGFß signalling
por: Wang, Xiaomeng, et al.
Publicado: (2013)

Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation
por: Yang, Jimin, et al.
Publicado: (2023)

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration
por: Mundo, Lucia, et al.
Publicado: (2021)

A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions
por: Liu, Chenghao, et al.
Publicado: (2020)

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
por: Zou, Yonghui, et al.
Publicado: (2022)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification
por: Grzesiak, Lucile, et al.
Publicado: (2023)

LRG1 is an adipokine that promotes insulin sensitivity and suppresses inflammation
por: Choi, Chan Hee J, et al.
Publicado: (2022)

LRG1 Associates with Iron Deficiency Anemia Markers in Adolescents
por: Alhammad, Rashed, et al.
Publicado: (2023)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)

Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
por: Yang, Yi, et al.
Publicado: (2020)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
por: Ma, Hong, et al.
Publicado: (2021)

Diagnostic Utility of Serum Leucine-Rich α-2-Glycoprotein 1 for Acute Appendicitis in Children
por: Tintor, Goran, et al.
Publicado: (2023)

Leucine-Rich Alpha-2-Glycoprotein1 Gene Interferes with Regulation of Apoptosis in Leukemia KASUMI-1 Cells
por: Xiao, Shishan, et al.
Publicado: (2018)

The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure
por: Song, Weihua, et al.
Publicado: (2015)

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
por: Hoefsmit, Esmee P., et al.
Publicado: (2023)

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
por: Zhang, Qian, et al.
Publicado: (2018)

One-pot thiol–amine bioconjugation to maleimides: simultaneous stabilisation and dual functionalisation
por: Wall, Archie, et al.
Publicado: (2020)

Chemical generation of checkpoint inhibitory T cell engagers for the treatment of cancer
por: Szijj, Peter A., et al.
Publicado: (2023)

Functional Evaluation of AMD-Associated Risk Variants of Complement Factor B
por: Pilotti, Camilla, et al.
Publicado: (2020)

Advances in targeting the folate receptor in the treatment/imaging of cancers
por: Fernández, Marcos, et al.
Publicado: (2017)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
por: Kajimoto, Etsuko, et al.
Publicado: (2020)

Leucine-Rich Alpha-2-Glycoprotein: A Novel Predictor of Diastolic Dysfunction
por: Loch, Alexander, et al.
Publicado: (2023)

ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand
por: Weivoda, Starchild, et al.
Publicado: (2008)

MPC-06 LRG1 HAS MULTIPLE POTENTIAL FOR CLINICOPATHOLOGICAL BIOMARKER OF GLIOBLASTOMA
por: Furuta, Takuya, et al.
Publicado: (2019)

Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy
por: Zhang, Afei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9lvhqccu6op87s9rq1bimo496g